De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept

De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial success.

This is episode three, where we discuss how to accelerate development and opportunities to differentiate your product through innovative and adaptive trial design. We focus on the importance of creating evidence packages that meet both regulatory and payer requirements, and the critical role of early value story development alongside target product profile (TPP) planning. 

Episode 1: Determine how to drive value in pre-clinical development
Episode 2: Focus on safety and efficacy and prove quickly that your product works 
Episode 3: Plan how to get to market quickly, post-proof of concept 
Episode 4: Implement market launch strategy, pre-approval
Episode 5: Expand the use and value of your product over time
 

Return to Insights Center